
### [NCIT:C7489](http://purl.obolibrary.org/obo/NCIT_C7489)
**Label:** Anal Canal Carcinoma

**Subclasses:** [NCIT:C96550](http://purl.obolibrary.org/obo/NCIT_C96550) (Anal Canal Large Cell Neuroendocrine Carcinoma), [NCIT:C96551](http://purl.obolibrary.org/obo/NCIT_C96551) (Anal Canal Small Cell Neuroendocrine Carcinoma), [NCIT:C7469](http://purl.obolibrary.org/obo/NCIT_C7469) (Anal Canal Squamous Cell Carcinoma), [NCIT:C133787](http://purl.obolibrary.org/obo/NCIT_C133787) (Anal Canal Cancer by AJCC v6 and v7 Stage), [NCIT:C96553](http://purl.obolibrary.org/obo/NCIT_C96553) (Anal Canal Mixed Adenoneuroendocrine Carcinoma), [NCIT:C7776](http://purl.obolibrary.org/obo/NCIT_C7776) (Stage III Anal Canal Cancer AJCC v6 and v7), [NCIT:C5612](http://purl.obolibrary.org/obo/NCIT_C5612) (Metastatic Anal Canal Carcinoma), [NCIT:C7794](http://purl.obolibrary.org/obo/NCIT_C7794) (Stage 0 Anal Canal Cancer AJCC v6 and v7), [NCIT:C9037](http://purl.obolibrary.org/obo/NCIT_C9037) (Stage I Anal Canal Cancer AJCC v6 and v7), [NCIT:C7775](http://purl.obolibrary.org/obo/NCIT_C7775) (Stage II Anal Canal Cancer AJCC v6 and v7), [NCIT:C6873](http://purl.obolibrary.org/obo/NCIT_C6873) (Stage IV Anal Canal Cancer AJCC v6 and v7), [NCIT:C7477](http://purl.obolibrary.org/obo/NCIT_C7477) (Paget Disease of the Anal Canal), [NCIT:C7471](http://purl.obolibrary.org/obo/NCIT_C7471) (Anal Canal Adenocarcinoma), [NCIT:C7793](http://purl.obolibrary.org/obo/NCIT_C7793) (Recurrent Anal Canal Carcinoma), [NCIT:C5606](http://purl.obolibrary.org/obo/NCIT_C5606) (Anal Mucinous Adenocarcinoma), [NCIT:C96549](http://purl.obolibrary.org/obo/NCIT_C96549) (Anal Canal Neuroendocrine Carcinoma), [NCIT:C96529](http://purl.obolibrary.org/obo/NCIT_C96529) (Anal Canal Undifferentiated Carcinoma), 

**Class expressions from DL-Learner:**

- [UBERON:0003342](http://purl.obolibrary.org/obo/UBERON_0003342) (mucosa of anal canal) 75.00%
- [UBERON:0000159](http://purl.obolibrary.org/obo/UBERON_0000159) (anal canal) 75.00%
- [UBERON:0004121](http://purl.obolibrary.org/obo/UBERON_0004121) (ectoderm-derived structure) 54.20%
- [UBERON:0010000](http://purl.obolibrary.org/obo/UBERON_0010000) (multicellular anatomical structure) 51.86%
- [UBERON:0000061](http://purl.obolibrary.org/obo/UBERON_0000061) (anatomical structure) 51.81%
- [UBERON:0000465](http://purl.obolibrary.org/obo/UBERON_0000465) (material anatomical entity) 51.70%
- [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 51.60%
- [BFO:0000040](http://purl.obolibrary.org/obo/BFO_0000040) (material entity) 51.59%
- [BFO:0000004](http://purl.obolibrary.org/obo/BFO_0000004) (null) 51.45%
- [BFO:0000002](http://purl.obolibrary.org/obo/BFO_0000002) (null) 51.44%
- Thing 50.92%
- [UBERON:0000344](http://purl.obolibrary.org/obo/UBERON_0000344) (mucosa) 33.22%
- [UBERON:0004923](http://purl.obolibrary.org/obo/UBERON_0004923) (organ component layer) 29.95%
- [UBERON:0004111](http://purl.obolibrary.org/obo/UBERON_0004111) (anatomical conduit) 28.92%
- [UBERON:0000064](http://purl.obolibrary.org/obo/UBERON_0000064) (organ part) 27.65%


